Maravai Lifesciences Holdings annual net debt
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Net Debt Growth & History (MRVI)
Maravai Lifesciences Holdings's net debt was $147.8M for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $147.8M | $93.5M | +172.26% |
| 2024 | 2024-12-31 | $54.3M | $18.3M | +50.79% |
| 2023 | 2023-12-31 | $36.0M | $82.9M | — |
| 2022 | 2022-12-31 | −$46.9M | −$70.8M | — |
| 2021 | 2021-12-31 | $23.9M | −$330.6M | −93.25% |
| 2020 | 2020-12-31 | $354.6M | — | — |
Maravai Lifesciences Holdings quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $106.6M | $5.4M | +5.37% |
| Q1 2026 | 2026-03-31 | $105.0M | $63.4M | +152.30% |
| Q4 2025 | 2025-12-31 | $147.8M | $93.5M | +172.26% |
| Q3 2025 | 2025-09-30 | $124.4M | $141.4M | — |
| Q2 2025 | 2025-06-30 | $101.2M | $112.5M | — |
| Q1 2025 | 2025-03-31 | $41.6M | $40.6M | +4068.44% |
| Q4 2024 | 2024-12-31 | $54.3M | $18.3M | +50.79% |
| Q3 2024 | 2024-09-30 | −$17.1M | −$52.2M | — |
| Q2 2024 | 2024-06-30 | −$11.3M | −$48.4M | — |
| Q1 2024 | 2024-03-31 | $998,000 | $25.5M | — |
| Q4 2023 | 2023-12-31 | $36.0M | $82.9M | — |
| Q3 2023 | 2023-09-30 | $35.1M | $74.6M | — |
| Q2 2023 | 2023-06-30 | $37.1M | $54.4M | — |
| Q1 2023 | 2023-03-31 | −$24.5M | −$122.9M | — |
| Q4 2022 | 2022-12-31 | −$46.9M | −$70.8M | — |
| Q3 2022 | 2022-09-30 | −$39.6M | −$79.7M | — |
| Q2 2022 | 2022-06-30 | −$17.3M | −$231.9M | — |
| Q1 2022 | 2022-03-31 | $98.5M | −$244.4M | −71.28% |
| Q4 2021 | 2021-12-31 | $23.9M | −$330.6M | −93.25% |
| Q3 2021 | 2021-09-30 | $40.2M | — | — |
| Q2 2021 | 2021-06-30 | $214.6M | — | — |
| Q1 2021 | 2021-03-31 | $342.8M | — | — |
| Q4 2020 | 2020-12-31 | $354.6M | — | — |
Maravai Lifesciences Holdings net debt trends
Over the last five fiscal years, Maravai Lifesciences Holdings's net debt decreased from $354.6M to $147.8M, a change of −$206.8M. The latest reported quarter, Q2 2026, shows $106.6M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗